Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_2
3
50%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%
unknown117%
completed233%
active_not_recruiting117%
recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
completedphase_1

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT03403049
recruitingphase_2

Predicting Esophageal Cancer Borders Using PET-Imaging

NCT06408116
active_not_recruitingnot_applicable

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

NCT02603341
not_yet_recruitingphase_2

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

NCT05548504
unknownphase_2

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

NCT04528394
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03403049Phase 1

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Completed
NCT06408116Phase 2

Predicting Esophageal Cancer Borders Using PET-Imaging

Recruiting
NCT02603341Not Applicable

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Active Not Recruiting
NCT05548504Phase 2

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Not Yet Recruiting
NCT04528394Phase 2

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

Unknown
NCT01365845Not Applicable

Proton Therapy for Lymph Nodes in Breast Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6